ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U102. A total of 33 filers reported holding ANTHERA PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2013 | $666,000 | – | 1,437,623 | – | 0.50% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 3,503,956 | $1,727,000 | 1.33% |
VHCP Management, LLC | 1,437,623 | $666,000 | 0.50% |
SABBY MANAGEMENT, LLC | 15,259,074 | $7,066,000 | 0.47% |
BVF INC/IL | 4,477,000 | $2,073,000 | 0.40% |
Broadfin Capital, LLC | 4,200,000 | $1,945,000 | 0.38% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 13,893,465 | $6,434,000 | 0.30% |
BAILARD, INC. | 1,934,848 | $896,000 | 0.16% |
Perceptive Advisors | 3,451,655 | $1,598,000 | 0.16% |
Orbimed Advisors | 7,462,000 | $3,433,000 | 0.07% |
J. Goldman & Co LP | 1,000,000 | $463,000 | 0.05% |